Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
PRO: hydroxyethylstarch can be safely used in the intensive care patient--the renal debate
Intensive Care Medicine, 06/19/09
Boldt J - Hyperoncotic HES should not be used in patients who are at risk of developing kidney dysfunction. In patients without preexisting kidney dysfunction there seems to be no negative effects of modern HES preparations. In septic patients with reduced kidney function HES should be used cautiously, because studies of these patients are not available. Dissolving HES in a balanced solution further improves the safety of HES with regard to kidney function. At present, there seems to be no good reason to generally ban use of HES in the patients.
Related Articles
The Science of Stewardship: Due Diligence for Kidney Donors and Kidney Function in Living Kidney Donation—Evaluation, Determinants, and Implications for Outcomes
Clinical Journal of the American Society of Nephrology, 10/08/09
Relevance Score: 71%
Kidney Disease Missed in Women
Ivanhoe, 11/04/09
Relevance Score: 70%
Rapid Decline of Kidney Function Increases Cardiovascular Risk in the Elderly
Journal of the American Society of Nephrology, 11/09/09
Relevance Score: 69%
Cause of Death in Multiorgan Donors and Its Relation to the Function of Transplanted Kidneys
Transplantation Proceedings, 11/10/09
Relevance Score: 68%
Understanding Diabetes Mellitus And Kidney Disease
Nephrology Nursing Journal, 10/02/09
Relevance Score: 68%
Today in Chronic Dz/Renal Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
Relation of Kidney Function and Albuminuria With Atrial Fibrillation (from the Heart and Soul Study)
The American Journal of Cardiology, 12/04/09
Methylarginines and mortality in patients with end stage renal disease: A prospective cohort study
Atherosclerosis, 12/04/09
In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke
Nephrology Dialysis Transplantation, 12/04/09
Article Search
Sponsor


See Latest Articles


